引用本文:郑 虹,赵明一,杨明华.焦亡的分子机制及其在血液肿瘤中的研究进展[J].中国临床新医学,2021,14(2):121-126.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3011次   下载 1247 本文二维码信息
码上扫一扫!
分享到: 微信 更多
焦亡的分子机制及其在血液肿瘤中的研究进展
郑 虹,赵明一,杨明华
410008 长沙,中南大学湘雅医院儿科(郑 虹);410013 长沙,中南大学湘雅三医院儿科(赵明一,杨明华)
摘要:
[摘要] 焦亡是一种新的程序性细胞死亡类型,它不同于凋亡和坏死,可以由各种细胞内或细胞外刺激引发。焦亡主要由Caspase-1/3/4/5/11和Gasdermin蛋白家族介导产生,具有细胞肿胀、胞膜溶解和炎症因子释放的特点。血液肿瘤亦称恶性血液病,包括急/慢性白血病、淋巴瘤、多发性骨髓瘤、骨髓增生异常综合征等,以恶性转化的造血干细胞异常分化和增殖为特征,是严重威胁人类健康的恶性疾病。近年来,随着细胞焦亡研究的兴起,很多学者通过对血液肿瘤中细胞焦亡机制的深入探究,发现血液肿瘤的新治疗靶点,并研究出相应的药物,揭示了焦亡在血液肿瘤发病机制中的作用,或将成为血液肿瘤的临床诊断、靶向治疗、预后评估的新方向。该文就焦亡的分子机制、焦亡在血液肿瘤中的相关研究进展进行综述,为更深入研究焦亡在血液肿瘤中的作用提供一些参考。
关键词:  焦亡  Caspase家族  Gasdermin家族  急性白血病  癌症治疗
DOI:10.3969/j.issn.1674-3806.2021.02.02
分类号:R 733
基金项目:国家自然科学基金面上项目(编号:81974000)
Molecular mechanism of pyroptosis and its research progress in hematological tumors
ZHENG Hong, ZHAO Ming-yi, YANG Ming-hua
Department of Pediatrics, Xiangya Hospital of Central South University, Changsha 410008, China
Abstract:
[Abstract] Pyroptosis is a newly identified type of programmed cell death that is different from apoptosis and necrosis and can be initiated in response to various intracellular or extracellular stimuli. Pyroptosis is mainly mediated by Caspase-1/3/4/5/11 and Gasdermin family, and characterized by cell swelling, membrane lysis and release of pro-inflammatory factors. Hematological tumors, also known as malignant hematological diseases, including acute/chronic leukemia, lymphoma, multiple myeloma, myelodysplastic syndrome and so on, are characterized by abnormal differentiation and proliferation of malignant transformed hematopoietic stem cells. Hematological tumors are malignant diseases that seriously threaten human health. In recent years, with the rise of the study of pyroptosis, many scholars have found new therapeutic targets for hematological tumors and developed corresponding drugs through in-depth exploration of the mechanism of pyroptosis in hematological tumors, revealing the role of pyroptosis in the pathogenesis of hematological tumors, which may become a new direction of clinical diagnosis, targeted therapy and prognosis evaluation of hematological tumors. In this paper, we review the molecular mechanism of pyroptosis and the related research progress of pyroptosis in hematological tumors, so as to provide some references for further research on the role of pyroptosis in hematological tumors.
Key words:  Pyroptosis  Caspase family  Gasdermin family  Acute leukemia  Cancer treatment